Helixgate https://validator.w3.org/feed/docs/rss2.html From fragile skin to living medicine: Lessons from RDEB STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more China Sets Framework for Advanced Therapeutic Development Moderna mulls deals to rescue German BioNTech plants from closure: report Nirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Tech Six of the biggest health news stories today Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution Biogen makes up to $1B immuno play with RayThera takeover RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t new GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say Personalized Cartilage Graft Developed for Life-Threatening Infant Airway Narrowing STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept Super-potent synthetic opioids called nitazenes are spreading across the U.S. Opinion: Congress should embrace strategic health diplomacy Ones to watch: 4 biotechs with recent Series B raises (that are also hiring) On the chopping block? When layoffs may and may not lurk around the corner Convert nonresponder insights into smarter drug development strategies in immunology Kardigan extends biotech’s streak of big IPOs with $400M haul FTC, four state AGs sue transgender health group over care standards Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing UniQure to file gene therapy for approval, reflecting major shifts at FDA Analytics Map Purification Optimization Tradeoffs Therapy enables 89% survival rate in myeloma patients  Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B Age-Related Inflammation Linked to R-Loop Nucleic Acids, Opens Therapies UniQure plans resubmission for Huntington’s gene therapy after FDA reverses course—again UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far? Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more PwC declares biopharma ecosystem ‘back to full health’ as M&A buoys sector A new Westlake-backed biotech takes aim at migraines Putting the wrong foot forward: 5 tricky interview questions Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments Engineering a robust and autonomous biological funneling for efficient valorization of lignin-related aromatics Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models Six Takeaways from the Danaher Bioprocessing Summit Single-Cell RNA Sequencing Reveals Gene Activity Changes in Crohn’s Disease STAT+: How a biotech turned a trial failure into an AI model STAT+: Shingles vaccine may lower dementia risk, new study finds Lilly buys non-opioid pain drugmaker 4E FDA, Moderna appear aligned on mRNA flu shot heading into adcomm The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations Amenable FDA review bodes well for Moderna’s mRNA flu shot ahead of adcomm grilling Home